As Yuman Fong has said there is no reason that CF33 won’t work in humans exactly as it did in mice. This is a virus not a small molecule drug. And IMU already had mice data on AZER-Cel as a cd29 targeted CarT therapy.
Your endless negativity seems to stem more from dissatisfaction with the shareprice than it does from rigorous analysis of the science.
As LC said “ cancer therapy development is not for bedwetters”
This company is going great it’s the shareholders who are the weakest part of the company. Looking fwd to the day when 27000 small holders are replaced by 20 big institutions.
Media Thread, page-14008
-
- There are more pages in this discussion • 657 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |